Volume maintaining osteoinductive/osteoconductive compositions
    6.
    发明授权
    Volume maintaining osteoinductive/osteoconductive compositions 有权
    体积维持骨诱导/骨传导组合物

    公开(公告)号:US08197474B2

    公开(公告)日:2012-06-12

    申请号:US13185553

    申请日:2011-07-19

    IPC分类号: A61F2/28

    CPC分类号: A61K35/32 Y10S606/909

    摘要: An osteoinductive/osteoconductive composition prepared from a quantity, of demineralized fibrous bone elements possessing an average surface area to volume ratio of about 100:1 to about 20:1, a quantity of mostly shaped regular non-fibrous bone elements possessing an average surface area to volume ratio of about 10:1 or less and a sufficient quantity of biocompatible fluid carrier sufficient to provide the composition as a deformable mass is provided herein. Also provided is a method of using the composition to repair a bone defect site.

    摘要翻译: 由一定数量的具有约100:1至约20:1的平均表面积与体积比的软化纤维骨元素制备的骨诱导/骨传导组合物,具有平均表面积的大多数成形的规则非纤维骨元素 体积比为约10:1或更低,并且足够量的足以提供组合物作为可变形物质的生物相容性流体载体在本文中提供。 还提供了使用该组合物修复骨缺损部位的方法。

    VOLUME MAINTAINING OSTEOINDUCTIVE/OSTEOCONDUCTIVE COMPOSITIONS
    7.
    发明申请
    VOLUME MAINTAINING OSTEOINDUCTIVE/OSTEOCONDUCTIVE COMPOSITIONS 有权
    体积维持机械/磁性组合物

    公开(公告)号:US20110274668A1

    公开(公告)日:2011-11-10

    申请号:US13185553

    申请日:2011-07-19

    IPC分类号: A61K35/32 A61P19/00

    CPC分类号: A61K35/32 Y10S606/909

    摘要: An osteoinductive/osteoconductive composition prepared from a quantity, of demineralized fibrous bone elements possessing an average surface area to volume ratio of about 100:1 to about 20:1, a quantity of mostly shaped regular non-fibrous bone elements possessing an average surface area to volume ratio of about 10:1 or less and a sufficient quantity of biocompatible fluid carrier sufficient to provide the composition as a deformable mass is provided herein. Also provided is a method of using the composition to repair a bone defect site.

    摘要翻译: 由一定数量的具有约100:1至约20:1的平均表面积与体积比的软化纤维骨元素制备的骨诱导/骨传导组合物,具有平均表面积的大多数成形的规则非纤维骨元素 体积比为约10:1或更低,并且足够量的足以提供组合物作为可变形物质的生物相容性流体载体在本文中提供。 还提供了使用该组合物修复骨缺损部位的方法。

    Volume maintaining osteoinductive/osteoconductive compositions
    8.
    发明授权
    Volume maintaining osteoinductive/osteoconductive compositions 有权
    体积维持骨诱导/骨传导组合物

    公开(公告)号:US08002813B2

    公开(公告)日:2011-08-23

    申请号:US12548029

    申请日:2009-08-26

    IPC分类号: A61F2/28

    CPC分类号: A61K35/32 Y10S606/909

    摘要: An osteoinductive/osteoconductive composition prepared from a quantity, of demineralized fibrous bone elements possessing an average surface area to volume ratio of about 100:1 to about 20:1, a quantity of mostly shaped regular non-fibrous bone elements possessing an average surface area to volume ratio of about 10:1 or less and a sufficient quantity of biocompatible fluid carrier sufficient to provide the composition as a deformable mass is provided herein. Also provided is a method of using the composition to repair a bone defect site.

    摘要翻译: 由一定数量的具有约100:1至约20:1的平均表面积与体积比的软化纤维骨元素制备的骨诱导/骨传导组合物,具有平均表面积的大多数成形的规则非纤维骨元素 体积比为约10:1或更低,并且足够量的足以提供组合物作为可变形物质的生物相容性流体载体在本文中提供。 还提供了使用该组合物修复骨缺损部位的方法。

    Osteoimplant and method for making same
    9.
    发明授权
    Osteoimplant and method for making same 有权
    植骨及其制作方法

    公开(公告)号:US07179299B2

    公开(公告)日:2007-02-20

    申请号:US10285715

    申请日:2002-11-01

    IPC分类号: A61F2/28

    摘要: A method of manufacturing an osteoinductive osteoimplant is provided which comprises the steps of: demineralizing part or all of at least one surface of a monolithic section of cortical bone to a depth of at least about 100 microns; and, configuring the monolithic section of cortical bone to provide an osteoimplant possessing an outer surface possessing at least one demineralized zone and a non-demineralized zone. An implant produced according to the above method demonstrates improved osteoinduction without producing any clinically significant reduction of strength in critical regions of the osteoimplant.

    摘要翻译: 提供了一种制造骨诱导性骨植入物的方法,其包括以下步骤:将至少一个皮质骨整体部分的至少一个表面的部分或全部软化至至少约100微米的深度; 以及配置皮质骨的整体部分以提供具有外表面的骨植入物,所述外表面具有至少一个脱矿质区和非脱矿质区。 根据上述方法制备的植入物表现出改善的骨诱导,而不会在骨植入物的临界区域中产生任何临床显着的强度降低。